Catalyst Pharmaceuticals Historical PE Ratio image   This CPRX PE ratio history page last updated 4/23/2024
Catalyst Pharmaceuticals Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q4 2023
2/28/2024
14.560.532.126.9
Q3 2023
11/8/2023
12.540.491.966.4
Q2 2023
8/9/2023
14.120.532.126.7
Q1 2023
5/10/2023
17.510.411.6410.7
Q4 2022
3/15/2023
14.340.311.2411.6
Q3 2022
11/9/2022
14.510.261.0414.0
Q2 2022
8/9/2022
10.600.281.129.5
Q1 2022
5/10/2022
6.930.120.4814.4
Q4 2021
3/16/2022
7.890.090.3621.9
Q3 2021
11/9/2021
6.170.100.4015.4
Q2 2021
8/9/2021
5.760.110.4413.1
Q1 2021
5/10/2021
4.820.070.2817.2
Q4 2020
3/15/2021
3.940.110.449.0
Q3 2020
11/9/2020
3.310.130.526.4
Q2 2020
8/10/2020
4.260.090.3611.8
Q1 2020
5/11/2020
5.050.100.4012.6
Q4 2019
3/16/2020
2.610.070.289.3
Q3 2019
11/12/2019
4.910.130.529.4
Q2 2019
8/7/2019
5.130.100.4012.8
Q1 2019
5/13/2019
3.16-0.01-0.04NA
Q4 2018
3/18/2019
3.08-0.14-0.56NA
Q3 2018
11/7/2018
3.15-0.08-0.32NA
Q2 2018
8/7/2018
2.98-0.06-0.24NA
Q1 2018
5/9/2018
2.80-0.06-0.24NA
Q4 2017
3/14/2018
2.98-0.06-0.24NA
Q3 2017
11/8/2017
2.99-0.05-0.20NA
Q2 2017
8/9/2017
2.88-0.05-0.20NA
Q1 2017
5/10/2017
1.83-0.06-0.24NA
Q4 2016
3/15/2017
1.55-0.05-0.20NA
Q3 2016
11/9/2016
1.03-0.05-0.20NA
Q2 2016
8/9/2016
0.79-0.06-0.24NA
Q1 2016
5/10/2016
0.64-0.07-0.28NA
Q4 2015
3/15/2016
1.12-0.07-0.28NA
Q3 2015
11/9/2015
3.20-0.06-0.24NA
Q2 2015
8/10/2015
4.37-0.06-0.24NA
Q1 2015
5/11/2015
3.41-0.06-0.24NA
Q4 2014
3/16/2015
4.44-0.05-0.20NA
Q3 2014
11/14/2014
2.66-0.06-0.24NA
Q2 2014
8/14/2014
2.19-0.05-0.20NA
Q1 2014
5/16/2014
1.82-0.07-0.28NA
Q4 2013
3/19/2014
2.25-0.05-0.20NA
Q3 2013
11/13/2013
1.32-0.13-0.52NA
Q2 2013
8/15/2013
1.34-0.06-0.24NA
Q1 2013
5/16/2013
0.83-0.04-0.16NA
Q4 2012
4/2/2013
0.47-0.14-0.56NA
Q3 2012
11/15/2012
0.41-0.08-0.32NA
Q2 2012
8/15/2012
1.40-0.01-0.04NA
Catalyst Pharmaceuticals PE History Chart
PeriodPriceAdj. EPSTTMPE
Q4 2023
2/28/2024
14.560.531.967.4
Q3 2023
11/8/2023
12.540.491.747.2
Q2 2023
8/9/2023
14.120.531.2511.3
Q1 2023
5/10/2023
17.510.410.9817.9
Q4 2022
3/15/2023
14.340.310.8516.9
Q3 2022
11/9/2022
14.510.260.7519.3
Q2 2022
8/9/2022
10.600.280.4921.6
Q1 2022
5/10/2022
6.930.120.3122.4
Q4 2021
3/16/2022
7.890.090.3026.3
Q3 2021
11/9/2021
6.170.100.3915.8
Q2 2021
8/9/2021
5.760.110.4213.7
Q1 2021
5/10/2021
4.820.070.4012.1
Q4 2020
3/15/2021
3.940.110.439.2
Q3 2020
11/9/2020
3.310.130.398.5
Q2 2020
8/10/2020
4.260.090.3910.9
Q1 2020
5/11/2020
5.050.100.4012.6
Q4 2019
3/16/2020
2.610.070.299.0
Q3 2019
11/12/2019
4.910.130.0861.4
Q2 2019
8/7/2019
5.130.10-0.13NA
Q1 2019
5/13/2019
3.16-0.01-0.29NA
Q4 2018
3/18/2019
3.08-0.14-0.34NA
Q3 2018
11/7/2018
3.15-0.08-0.26NA
Q2 2018
8/7/2018
2.98-0.06-0.23NA
Q1 2018
5/9/2018
2.80-0.06-0.22NA
Q4 2017
3/14/2018
2.98-0.06-0.22NA
Q3 2017
11/8/2017
2.99-0.05-0.21NA
Q2 2017
8/9/2017
2.88-0.05-0.21NA
Q1 2017
5/10/2017
1.83-0.06-0.22NA
Q4 2016
3/15/2017
1.55-0.05-0.23NA
Q3 2016
11/9/2016
1.03-0.05-0.25NA
Q2 2016
8/9/2016
0.79-0.06-0.26NA
Q1 2016
5/10/2016
0.64-0.07-0.26NA
Q4 2015
3/15/2016
1.12-0.07-0.25NA
Q3 2015
11/9/2015
3.20-0.06-0.23NA
Q2 2015
8/10/2015
4.37-0.06-0.23NA
Q1 2015
5/11/2015
3.41-0.06-0.22NA
Q4 2014
3/16/2015
4.44-0.05-0.23NA
Q3 2014
11/14/2014
2.66-0.06-0.23NA
Q2 2014
8/14/2014
2.19-0.05-0.30NA
Q1 2014
5/16/2014
1.82-0.07-0.31NA
Q4 2013
3/19/2014
2.25-0.05-0.28NA
Q3 2013
11/13/2013
1.32-0.13-0.37NA
Q2 2013
8/15/2013
1.34-0.06-0.32NA
Q1 2013
5/16/2013
0.83-0.04-0.27NA
Q4 2012
4/2/2013
0.47-0.14NANA
Q3 2012
11/15/2012
0.41-0.08NANA
Q2 2012
8/15/2012
1.40-0.01NANA
Quotes delayed 20 minutes

Email EnvelopeFree CPRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Catalyst Pharmaceuticals (CPRX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CRBP PE Ratio History
CRBU PE Ratio History
CRDF PE Ratio History
CRGX PE Ratio History
CRIS PE Ratio History
CRL PE Ratio History
CRMD PE Ratio History
CRNX PE Ratio History
CRTX PE Ratio History
CRVL PE Ratio History
How should the CPRX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Catalyst Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CPRX Historical PE Ratio page.

What is the average historical PE for CPRX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CPRX historical PE ratio using the annualized quarterly earnings method works out to 11.5.

What is the average historical PE for CPRX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CPRX historical PE ratio using the TTM earnings method works out to 16.9.

What is the average historical PE for CPRX based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The CPRX historical PE ratio using the annualized median TTM earnings method works out to 2.04.

On this page we presented the Catalyst Pharmaceuticals Historical PE Ratio information for Catalyst Pharmaceuticals' stock. The average CPRX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 11.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CPRX historical PE based on this TTM earnings result method is 16.9. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CPRX historical PE result, against the recent PE: when this page was posted on 4/22/2024, the most recent closing price for CPRX had been 15.10, and the most recent quarterly earnings result, annualized, was 2.12. Meanwhile, the most recent TTM earnings summed to 1.96. From these numbers, we calculate the recent CPRX PE on 4/22/2024 based on annualized quarterly EPS was 7.1. Based on CPRX's history, that recent PE is low relative to the historical average, with the recent PE 38.3% lower than the historical average PE across our data set for Catalyst Pharmaceuticals. Looking at the recent CPRX PE on 4/22/2024 based on TTM EPS, we calculate the ratio at 7.7. Based on CPRX's history, that recent PE is low relative to the historical average, with the recent PE 54.4% lower than the average PE across our Catalyst Pharmaceuticals data set with TTM EPS used in the calculation at each period.

Another interesting CPRX historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for CPRX, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for CPRX, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.41, 0.49, 0.53, and 0.53. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.49 and 0.53 — which gives us the median of 0.51. Basically the way to think about this 0.51 number is this: for the trailing four earnings reports, 0.51 marks the "middle ground" number where CPRX has reported a value higher than 0.51 half the time, and has reported a value lower than 0.51 half the time. Annualizing that median value then gets us to 2.04/share, which we use as the denominator in our next PE calculation. With 15.10 as the numerator (as of 4/22/2024), the calculation is then 15.10 / 2.04 = 7.4 as the CPRX PE ratio as of 4/22/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on CPRX or any other given stock, valuation analysis for CPRX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Catalyst Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CPRX. Thanks for visiting, and the next time you need to research CPRX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of IMNM, BX Technical Analysis, Funds Holding FH.

 

Catalyst Pharmaceuticals Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.